How to Accelerate Your Global Trials and CDx Development with Approved and Novel Biomarkers
Time: 8:20 am
day: Day 1 AM
Details:
- Best practices for CDx development with approved tissue and liquid biopsy tests in US & Japan
- Our experience facilitating global trials, from Europe under IVDR to profiling in China
- How to use novel biomarkers – like our tumor fraction, HRD signature – to identify more patients for trials and gain new molecular insights to inform clinical development
